Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells

SIMPLE SUMMARY: Glioblastoma (GBM) remains a particularly challenging cancer, with an aggressive phenotype and few promising treatment options. Future therapy will rely heavily on diagnosing and targeting aggressive GBM cellular phenotypes, both before and after drug treatment, as part of personaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapovalov, Vladimir, Kopanitsa, Liliya, Pruteanu, Lavinia-Lorena, Ladds, Graham, Bailey, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345128/
https://www.ncbi.nlm.nih.gov/pubmed/34359681
http://dx.doi.org/10.3390/cancers13153780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345128/
https://www.ncbi.nlm.nih.gov/pubmed/34359681
http://dx.doi.org/10.3390/cancers13153780

Ejemplares similares